#United States #McLean #Nexus Health #Clearsight Advisors #Stratis Group

Clearsight Advisors Facilitates Strategic Acquisition of Stratis Group by Nexus Health

On March 19, 2026, Clearsight Advisors, Inc., a prominent name in investment banking, proudly announced a significant achievement in the Healthcare and Life Sciences domain. The firm acted as the exclusive financial consultant for Stratis Group, a consulting entity known for its innovative approaches in commercialization strategy, which has now been acquired by Nexus Health, a part of The Lockwood Group, LLC.

Founded in 2014, Stratis Group has carved a niche in delivering comprehensive solutions across commercialization strategies, patient service innovations, market access, and analytics tailored for clients within the pharmaceutical and biotechnology sectors. Their unique combination of data-driven insights, customer research, and adaptive strategies has set them apart in an increasingly competitive landscape. By employing effective methodologies such as health economics and outcomes research (HEOR), real-world evidence generation, and brand analytics, Stratis has significantly enhanced client engagement and product positioning throughout the commercialization journey.

Meanwhile, Nexus Health, part of The Lockwood Group, is a consultancy specializing in market access and commercialization solutions, providing life sciences companies with integrated, data-driven services. In recent years, Nexus has expanded its skill set to include strategic consulting, accessibilities solutions, and value communications, capitalizing on Lockwood’s broader capabilities in medical communications and engagement strategies.

The recent acquisition aims to amplify their collective capabilities, promising an enhanced offering for clients through complementary services. As Stratis joins Nexus Health, they aim to deliver extensive commercialization and market access solutions with greater efficiency and resourcefulness. This strategic alignment is expected to bolster both firms’ service offerings across patient engagement, analytics, and market access optimization—paving the way for a richer experience for healthcare organizations impacting patient care.

Joseph Musumeci, Co-Founder of Stratis Group, expressed profound appreciation for Clearsight's role in this journey, stating, "Clearsight's team was a true partner from day one. They understood our market and provided invaluable guidance at every stage of the process." His sentiments were echoed by Tory Steel, a Managing Director at Clearsight Advisors, who emphasized Stratis's robust domain expertise and the importance of this milestone transaction in addressing market access challenges effectively.

Austin Kuhn, another Director at Clearsight, praised Stratis’s innovative approach that led them to identify significant points of friction in the commercialization process, allowing them to build targeted solutions that resulted in impressive growth. The transaction signifies a new chapter for Stratis Group as they look to expand their influence and boost growth within Lockwood's healthcare-focused service landscape.

The Clearsight team included notable professionals such as Tory Steel, Greg Treger, Austin Kuhn, Jake Kohlbrenner, Miles Gally, and Brandon Curran, who collectively contributed to the diligence and execution of this complex deal. Clearsight Advisors remains committed to delivering exceptional investment banking services to growing companies across various industries, particularly in healthcare and life sciences, ensuring a promising future for the organizations they assist.

This acquisition exemplifies the growing trend of consolidation within the healthcare consulting sector as firms seek to enhance their capabilities and expand their reach in ever-evolving marketplaces. As Stratis integrates with Nexus Health, the synergy between the two organizations is set to support clients with advanced solutions from the early planning stages of commercialization through to product launches and optimization. The combination is expected to significantly impact the healthcare consulting industry, enhancing operational efficiencies and patient engagement strategies significantly.

About Clearsight Advisors

Clearsight Advisors operates as a premier investment banking firm dedicated to providing top-tier M&A and capital-raising solutions. As a wholly-owned subsidiary of Regions Financial Corporation, Clearsight Advisors is committed to excellence and integrity, ensuring all securities offerings are conducted through licensed broker-dealers. For further details, please visit Clearsight Advisors.